Delivery Order SPE2DB22D2214-SPE2DB25FS3RB

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $68K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $15,481.60 delivery order contract is for the drug Biktarvy, which is used to treat HIV, and has a completion date of December 3, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $13,656.10 and is a delivery order contract with a firm fixed price pricing type. The contract is for the supply of the drug Biktarvy, a prescription medication used for the treatment of HIV-1 infection. The contract has an ultimate completion date of January 6, 2025. This award is part of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,427.09, is for the delivery of Biktarvy, a prescription medication used to treat HIV-1 infection. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,690.18, is for the provision of Biktarvy 50-200-25 mg tablet, a medication used in the treatment of HIV. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,625.39, is a Firm Fixed Price Delivery Order for the provision of the drug Biktarvy, a medication used to treat HIV. The contract has an ultimate completion date of December 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $40,333.15, is for the delivery of the drug Biktarvy, a medication used to treat HIV. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 23, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,696.76, is for the delivery of Biktarvy 50-200-25 mg tablets, which are used to treat HIV. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of May 29, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $41,322.09 and is a delivery order for the medication Biktarvy, a combination drug used to treat HIV. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed price contract. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the HIV medication Biktarvy in 30-count tablet packages. The contract, valued at $17,907.06, was awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating open competition. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,402.38, is for the delivery of the HIV medication Biktarvy 50-200-25 mg tablets. This is a firm fixed-price delivery order contract that runs through February 3, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS3RB
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $68,293.08, is for the delivery of the drug Biktarvy, a combination tablet used to treat HIV-1 infection. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of February 4, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 10:10 AM